triheptanoin · Ultragenyx Pharm Inc · NDA 213687
Dojolvi
Earliest generic entry, as listed
14 Nov 2034
Blocked by patent: US 12551461.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12551461 | product | 14 Nov 2034 |
| US 8697748 | product | 28 Apr 2029 |
Exclusivities · 1 unexpired
| ODE-311 | orphan drug (7 years) | 30 Jun 2027 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 213687 · 001 · RLD | liquid, oral | 100% w/w | 14 Nov 2034 |